Private Asset Management Trimmed By $10.82 Million Its Sempra Energy (SRE) Holding; Sphera Funds Management LTD Trimmed Its Adamas Pharmaceuticals (ADMS) Holding

Sphera Funds Management Ltd decreased Adamas Pharmaceuticals Inc (ADMS) stake by 40.92% reported in 2017Q3 SEC filing. Sphera Funds Management Ltd sold 80,000 shares as Adamas Pharmaceuticals Inc (ADMS)’s stock declined 13.31%. The Sphera Funds Management Ltd holds 115,500 shares with $2.45M value, down from 195,500 last quarter. Adamas Pharmaceuticals Inc now has $771.52 million valuation. The stock increased 5.35% or $1.72 during the last trading session, reaching $33.87. About 612,876 shares traded. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has declined 0.40% since January 10, 2017 and is downtrending. It has underperformed by 17.10% the S&P500.

Private Asset Management Inc decreased Sempra Energy (SRE) stake by 89.53% reported in 2017Q3 SEC filing. Private Asset Management Inc sold 10,826 shares as Sempra Energy (SRE)’s stock rose 5.34%. The Private Asset Management Inc holds 1,266 shares with $1.27 million value, down from 12,092 last quarter. Sempra Energy now has $27.04 billion valuation. The stock decreased 0.79% or $0.86 during the last trading session, reaching $107.62. About 4.31 million shares traded or 142.39% up from the average. Sempra Energy (NYSE:SRE) has risen 8.27% since January 10, 2017 and is uptrending. It has underperformed by 8.43% the S&P500.

Sphera Funds Management Ltd increased Clovis Oncology Inc (NASDAQ:CLVS) stake by 65,000 shares to 158,000 valued at $13.02M in 2017Q3. It also upped Merck & Co Inc (NYSE:MRK) stake by 105,000 shares and now owns 425,000 shares. Shire Plc (NASDAQ:SHPG) was raised too.

Among 11 analysts covering Adamas Pharmaceuticals (NASDAQ:ADMS), 10 have Buy rating, 1 Sell and 0 Hold. Therefore 91% are positive. Adamas Pharmaceuticals had 26 analyst reports since August 7, 2015 according to SRatingsIntel. Needham maintained the stock with “Buy” rating in Friday, September 15 report. On Wednesday, August 9 the stock rating was maintained by Cowen & Co with “Buy”. Mizuho maintained the stock with “Buy” rating in Tuesday, June 6 report. As per Tuesday, January 19, the company rating was initiated by Mizuho. Piper Jaffray maintained it with “Buy” rating and $30.0 target in Tuesday, October 3 report. The company was initiated on Tuesday, September 22 by Aegis Capital. The rating was initiated by JMP Securities on Friday, April 1 with “Market Outperform”. The firm has “Buy” rating given on Tuesday, August 8 by Piper Jaffray. Northland Capital initiated it with “Buy” rating and $70.0 target in Wednesday, November 29 report. The rating was maintained by Piper Jaffray with “Buy” on Thursday, August 31.

Analysts await Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) to report earnings on February, 27. They expect $-1.15 EPS, down 69.12% or $0.47 from last year’s $-0.68 per share. After $-1.04 actual EPS reported by Adamas Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 10.58% negative EPS growth.

Investors sentiment increased to 1.19 in Q3 2017. Its up 0.18, from 1.01 in 2017Q2. It is positive, as 28 investors sold SRE shares while 168 reduced holdings. 62 funds opened positions while 172 raised stakes. 197.93 million shares or 1.07% less from 200.08 million shares in 2017Q2 were reported. Rocky Mountain Advisers Ltd Company holds 1,600 shares. Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0.06% invested in Sempra Energy (NYSE:SRE). Stonebridge Cap Limited Co invested 0.3% of its portfolio in Sempra Energy (NYSE:SRE). Millennium Ltd Liability Com holds 345,162 shares. Cleararc Inc stated it has 6,434 shares or 0.11% of all its holdings. 3,734 were reported by Gofen Glossberg Ltd Liability Il. Creative Planning invested in 0.01% or 22,717 shares. Verition Fund Ltd invested 0.12% in Sempra Energy (NYSE:SRE). Bankshares Of Montreal Can holds 0.03% of its portfolio in Sempra Energy (NYSE:SRE) for 297,687 shares. Shell Asset Management holds 0.12% or 66,058 shares in its portfolio. Strs Ohio reported 0.35% of its portfolio in Sempra Energy (NYSE:SRE). Thrivent Financial For Lutherans, a Minnesota-based fund reported 9,965 shares. Dekabank Deutsche Girozentrale holds 0.06% of its portfolio in Sempra Energy (NYSE:SRE) for 60,303 shares. M&T Bank & Trust holds 0.01% in Sempra Energy (NYSE:SRE) or 18,288 shares. Louisiana State Employees Retirement System holds 15,700 shares.

Among 9 analysts covering Sempra Energy (NYSE:SRE), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Sempra Energy has $134 highest and $108 lowest target. $118.11’s average target is 9.75% above currents $107.62 stock price. Sempra Energy had 18 analyst reports since September 15, 2015 according to SRatingsIntel. The stock has “Equal-Weight” rating by Barclays Capital on Thursday, June 8. BMO Capital Markets maintained the shares of SRE in report on Friday, August 4 with “Hold” rating. JP Morgan maintained it with “Neutral” rating and $124 target in Wednesday, November 1 report. The rating was maintained by RBC Capital Markets with “Buy” on Sunday, November 5. The stock of Sempra Energy (NYSE:SRE) earned “Hold” rating by BMO Capital Markets on Thursday, May 11. The firm has “Buy” rating by RBC Capital Markets given on Sunday, October 1. The stock of Sempra Energy (NYSE:SRE) has “Hold” rating given on Friday, December 22 by Bank of America. The stock of Sempra Energy (NYSE:SRE) has “Buy” rating given on Wednesday, October 11 by Goldman Sachs. The firm has “Outperform” rating by RBC Capital Markets given on Monday, January 25. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, August 27 report.

Analysts await Sempra Energy (NYSE:SRE) to report earnings on February, 27. They expect $1.39 earnings per share, down 8.55% or $0.13 from last year’s $1.52 per share. SRE’s profit will be $349.27 million for 19.36 P/E if the $1.39 EPS becomes a reality. After $1.04 actual earnings per share reported by Sempra Energy for the previous quarter, Wall Street now forecasts 33.65% EPS growth.